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Identifying measures that reliably and validly assess clinical impairment has important implications for
eating disorder (ED) diagnosis and treatment. The current study examined the psychometric properties
of the Clinical Impairment Assessment (CIA) in women at high risk for ED onset. Participants were 543
women (20.6  2.0 years) who were classiﬁed into one of three ED categories: clinical ED, high risk for
ED onset, and low risk control. Among high risk women, the CIA demonstrated high internal consistency
(a ¼ 0.93) and good convergent validity with disordered eating attitudes (rs ¼ 0.27e0.68, ps < 0.001).
Examination of the CIA’s discriminant validity revealed that CIA global scores were highest among
women with a clinical ED (17.7  10.7) followed by high risk women (10.6  8.5) and low risk controls
(3.0  3.3), respectively (p < 0.001). High risk women reporting behavioral indices of ED psychopathology (objective and/or subjective binge episodes, purging behaviors, driven exercise, and ED treatment history) had higher CIA global scores than those without such indices (ps < 0.05), suggesting good
criterion validity. These data establish the ﬁrst norms for the CIA in a United States sample. The CIA is
psychometrically sound among high risk women, and heightened levels of impairment among these
individuals as compared to low risk women verify the relevance of early intervention efforts.
Ó 2012 Elsevier Ltd. All rights reserved.
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Central to the deﬁnition of a mental disorder is the notion of
clinically signiﬁcant distress and disability resulting from behavioral or psychological patterns (American Psychiatric Association
[APA], 2000; APA, 2010). Disability refers to the experience of
clinical impairment in one or more important domains of functioning, including occupational, academic, social, and role domains
(APA, 2000; APA, 2010). Moving toward DSM-5, there is an
increasing recognition that clinical impairment is a critical criterion
to identify individuals in need of treatment because mental
disorder symptoms may not always be associated with subjective
emotional distress (Stein et al., 2010). The construct of clinical
impairment may be especially relevant to determining the clinical
signiﬁcance of eating disorder psychopathology because many
symptoms, such as intrusive thoughts related to an individual’s
shape and weight, can be ego-syntonic in nature (Polivy & Herman,
* Corresponding author. Washington University School of Medicine, Department
of Psychiatry, 660 South Euclid, Box 8134, St. Louis, MO 63110, USA. Tel.: þ1 314 286
2079; fax: þ1 314 286 2091.
E-mail address: wilﬂeyd@psychiatry.wustl.edu (D.E. Wilﬂey).
0005-7967/$ e see front matter Ó 2012 Elsevier Ltd. All rights reserved.
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2002). Moreover, clinical impairment is often what prompts individuals with eating disorders to seek treatment and is considered
a key treatment target and outcome measure (Fairburn, 2008).
Therefore, the current study sought to examine clinical impairment
among women with eating pathology.
Clinical impairment is a dimensional construct that varies
greatly across a continuum (Stein et al., 2010). Therefore, research is
needed to investigate clinical impairment in populations that vary
by symptom severity to enhance diagnostic and treatment efforts.
It is well established that full syndrome eating disorders are associated with marked clinical impairment as compared to individuals
with low eating disorder psychopathology (Hudson, Hiripi, Pope, &
Kessler, 2007; Swanson, Crow, Le Grange, Swendsen, & Merikangas,
2011). Preliminary evidence suggests that individuals with
subclinical levels of disordered eating attitudes and behaviors may
evidence psychological and medical consequences comparable to
their full syndrome counterparts (Ackard, Fulkerson, & NeumarkSztainer, 2011; Peebles, Hardy, Wilson, & Lock, 2010). There has
been no known empirical examination of the extent of clinical
impairment in a population at high risk for eating disorder onset,
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such as those with elevated weight and shape concerns (Jacobi
et al., 2011). An examination of clinical impairment across the
broad range of eating pathology and eating disorder risk status
would provide evidence for empirically distinguishing between
clinically signiﬁcant levels of impairment that indicate a need for
treatment, moderate yet elevated levels of clinical impairment that
identify high risk individuals and support the use of preventative
interventions, and milder forms of clinical impairment that may
not warrant intervention.
One criticism of the “clinical signiﬁcance criterion” for mental
disorders is that the constructs of distress and impairment are
somewhat ambiguous and can rely too heavily on subjective judgments to determine clinical signiﬁcance (Stein et al., 2010). The
identiﬁcation of psychometrically sound measures of clinical
impairment would help to standardize and clearly operationalize
this construct, thus bolstering researchers’ and clinicians’ conﬁdence in the utility of the clinical signiﬁcance criterion. The Clinical
Impairment Assessment (CIA) was developed as a brief self-report
questionnaire to assess the extent to which an individual’s eating
habits, exercising, or feelings about his or her shape, weight, or
eating impact daily functioning in psychosocial domains (Bohn &
Fairburn, 2008). The CIA is distinguished from other eating
disorder-related quality of life measures in that the CIA clearly
emphasizes the severity of impairment across important domains
of functioning that occurs as a direct consequence of an individual’s
eating disorder psychopathology, which has been suggested as
a critical feature for determining clinical impairment in the DSM-5
(Stein et al., 2010). Thus, establishing the psychometric properties of
the CIA in populations across a wide range of eating pathology and
eating disorder risk has the potential for broader implications for
clinical impairment assessment beyond the eating disorder ﬁeld.
Previous studies have established the psychometric properties
of the CIA in clinical and community samples, but none have
occurred among a high risk sample. The initial study of the CIA
occurred in women enrolled in an eating disorder treatment trial
(Bohn et al., 2008). The CIA demonstrated excellent internal
consistency and test-retest reliability in this sample (Bohn et al.,
2008). The CIA was also strongly correlated with self-reported
eating disorder psychopathology and clinician ratings of impairment at all time points throughout treatment, indicating good
construct validity (Bohn et al., 2008). Finally, the CIA had adequate
discriminant validity, such that a small sample of recovered
patients (n ¼ 37) reported signiﬁcantly less impairment than those
with full syndrome eating disorders (n ¼ 33) (Bohn et al., 2008). A
second study investigated the psychometric properties of the CIA in
a community sample of young women with low eating pathology
(Reas, Ro, Kapstad, & Lask, 2010). Again, the CIA had excellent
internal consistency and test-retest reliability as well as good
construct validity with eating pathology (Reas et al., 2010). In the
third study of the CIA, the measure was adapted to an interview
format for use among adolescent schoolgirls with clinical and
subclinical eating disorder symptoms from rural Fiji (Becker et al.,
2010). The CIA interview format was tested among 215 schoolgirls and found to be internally consistent and to have adequate
criterion and construct validity with measures of eating disorder
psychopathology (Becker et al., 2010). Taken together, these results
suggest that the CIA is a reliable measure in young women with full
syndrome eating disorders and community samples. The CIA has
also consistently demonstrated construct validity in previous
studies; however, there has been limited work on the criterion and
discriminant validity. An important next step in determining the
clinical utility of the CIA is to examine its psychometric properties
among individuals at high risk for eating disorder onset.
The establishment of norms for clinical impairment measures
such as the CIA provides a useful framework within which clinicians

can interpret varying levels of impairment severity. Normative data
may allow the CIA to serve as a potentially powerful tool to estimate
symptom severity and supplement clinicians’ decisions regarding
treatment planning. Mean CIA global scores in prior studies ranged
between 6 and 9 in healthy women from Sweden and Norway and
in adolescents from Fiji (Becker et al., 2010; Reas et al., 2010; Welch,
Birgegard, Parling, & Ghaderi, 2011). On the other hand, a mean CIA
global score of approximately 30 has been estimated for those
diagnosed with eating disorders in clinical samples from the United
Kingdom and Sweden (Bohn et al., 2008; Welch et al., 2011). To date,
there have been no known studies of the CIA within the United
States. Due to potential cultural differences, it is unclear as to
whether the CIA norms will be the same as in previous studies; thus
normative United States data for the CIA is important to inform the
generalizability of study ﬁndings.
The primary objective of the current study was to examine the
psychometric properties of the CIA for a sample of college-age
women at high risk for developing an eating disorder. We
hypothesized that the CIA would demonstrate excellent internal
consistency and good criterion and convergent validity in relation
to eating pathology among high risk women. We also expected to
replicate the CIA’s factor structure. In terms of discriminant validity,
we further anticipated that CIA global scores would increase as risk
level increased from low risk, high risk, to clinical eating disorder
groups. As a secondary objective, we sought to extend previous
studies by establishing norms across the spectrum of disordered
eating in sample from the United States and to compare these
norms with results from prior studies.
Methods
Participants
Participants were women at varying levels of eating disorder
risk between 18 and 25 years of age and had a body mass index
between 18 and 32 kg/m2. Women were recruited broadly from two
private universities and three public colleges/universities in the
Sacramento and San Francisco Bay areas and from one community
college, one public university, four small graduate schools/liberal
arts colleges, and three private universities in the Saint Louis
metropolitan area. The vast majority of these women were enrolled
in undergraduate or graduate level courses at these local universities and colleges. Interested women were excluded if they were
actively suicidal or psychotic, were suffering from bipolar disorder,
did not have regular Internet access, or resided outside the
metropolitan regions of the university sites. Women who reported
current prescription medication for mood or anxiety disorders
were included if their medication was stable for at least two weeks.
Procedures
Study participants were recruited via study ﬂiers posted at local
academic institutions, Facebook, Craigslist, campus email solicitations from study staff and campus leaders, and a recruitment
organization called Volunteers for Health (only at Washington
University). Recruitment materials were broadly targeted for
women who were concerned about their weight, wanting to feel
better about their body, experiencing interpersonal problems, and/
or having difﬁculty focusing on their schoolwork. Advertisements
also stated that the research team was studying the beneﬁts of
a program focused on improving body image and developing
healthy coping skills. Potential participants completed a brief
screening questionnaire through email or over the phone, and
women identiﬁed as potentially meeting study inclusion criteria
were asked to complete an in-person assessment. Each participant
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was screened by trained assessors for psychiatric comorbidity and
a clinical eating disorder diagnosis using two semi-structured
diagnostic interviews, the Structured Clinical Interview for DSMIV Axis I Disorders (First, Spitzer, Gibbon, & Williams, 2002) and
the Eating Disorder Examination (Fairburn & Cooper, 1993).
Women were included in the current study if they were identiﬁed as meeting criteria for one of three eating disorder symptom
or risk categories: clinical eating disorder, high risk for eating
disorder onset, or low risk control. Women who met DSM-IV
criteria for an eating disorder (i.e., anorexia nervosa, bulimia
nervosa, binge eating disorder, or eating disorder not otherwise
speciﬁed) based on data from the Eating Disorder Examination
were characterized as being of clinical eating disorder status. The
Weight Concerns Scale (Killen et al., 1994) is a 5-item self-report
questionnaire with scores ranging 0 to 100 that was used to
determine risk status. “High risk” status was deﬁned as scoring 47
or higher on the Weight Concerns Scale (Killen et al., 1996),
reporting being very afraid or terriﬁed of gaining 3 pounds, or
reporting that weight was more important than most things or the
most important thing in the individual’s life (Jacobi, Abascal, &
Taylor, 2004; Taylor et al., 2006). Women identiﬁed as “low risk
control” status did not meet any of the clinical eating disorder or
high risk status criteria and served as a control group for the
current study.
Following the semi-structured interviews, interested and
eligible women completed self-report questionnaires. The institutional review board at each of the participating sites approved the
study protocol, and all participants provided informed consent.
Measures were completed pre-treatment, between September,
2009 and April, 2010.
Measures
Clinical Impairment Assessment 3.0 (CIA)
The CIA 3.0 is a 16-item, self-report questionnaire designed to
measure psychosocial impairment due to eating disorder features
in the past 28 days (Bohn & Fairburn, 2008). Items are rated on a 4point Likert-like scale, ranging from 0 (“Not at all”) to 3 (“A Lot”).
The CIA generates three subscales to capture clinical impairment
across speciﬁc domains, including personal, social, and cognitive. A
CIA global score is calculated as a severity index (ranging from 0 to
48), with higher scores indicating greater severity of clinical
impairment. The CIA has demonstrated high levels of internal
consistency, test-retest reliability, sensitivity to change, construct
validity, and discriminant validity in community and clinical
samples of young women (Bohn et al., 2008; Reas et al., 2010).
Eating Disorder Examination, 14th Edition Diagnostic Version (EDE
14.0)
The EDE 14.0 is a semi-structured interview that generates
eating disorder diagnoses based on DSM-IV criteria (Fairburn &
Cooper, 1993). In addition to determining eating disorder diagnoses, the EDE was administered to assess the frequency of
objective binge episodes (deﬁned as eating an unambiguously large
amount of food with a sense of loss of control), subjective binge
episodes (deﬁned as experiencing a sense of loss of control in
conjunction with eating a non-unambiguously large amount of
food that is perceived as excessive by the participant), purging
behaviors (vomiting, laxatives, diuretics), and driven exercise in the
previous 3 months. The EDE has demonstrated high internal
consistency, discriminative validity, concurrent validity, test-retest
reliability, and sensitivity to change (Cooper, Cooper, & Fairburn,
1989; Cooper & Fairburn, 1987; Grilo, Masheb, Lozano-Blanco, &
Barry, 2003; Rizvi, Peterson, Crow, & Agras, 2000; Rosen, Vara,
Wendt, & Leitenberg, 1990).
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Eating Disorder Examination e Questionnaire (EDE-Q)
The EDE-Q is a 39-item, self-report version of the EDE that was
used to assess eating disorder psychopathology in the previous 28
days, yielding a global score and four subscale scores (restraint,
eating concern, weight concern, shape concern). EDE-Q global and
subscale scores range from 0 to 6, with higher scores indicating
greater pathology. The EDE-Q has been shown to be internally
consistent, temporally stable, and valid (Luce & Crowther, 1999;
Mond, Hay, Rodgers, & Owen, 2006; Mond, Hay, Rodgers, Owen, &
Beumont, 2004; Peterson et al., 2007; Reas, Grilo, & Masheb, 2006).
Beck Depression Inventory-II (BDI-II)
The BDI-II is a 21-item, self-report questionnaire that assesses
depressive symptoms in the previous two weeks (Beck, Steer, &
Brown, 1996). The BDI is a widely-used measure of depressive
symptoms in clinical and community samples, and has shown
internal consistency, reliability, and validity in college student
samples (Beck, Steer, & Carbin, 1988; Sprinkle et al., 2002; Storch,
Roberti, & Roth, 2004).
State-Trait Anxiety Inventory (STAI)
The STAI consists of two, 20-item scales for measuring anxiety
as an emotional state (state anxiety) and anxiety proneness as
a personality trait (trait anxiety) (Spielberger, Gorsuch, & Lushene,
1970). Only the state anxiety subscale was used in the current
analyses. The STAI has been shown to have good construct validity,
test-retest reliability, and sensitivity to change (Spielberger, 1989).
Socio-demographic characteristics
A self-report measure assessing participant demographic characteristics included age (years), racial/ethnic background (coded as nonHispanic White, African/African American, Asian/Asian American,
Hispanic/Latino/Mexican American, Multi-ethnic, and Other), and
education status of the participant’s most educated caregiver (coded
as Less than High School, High School Graduate, College Graduate, and
Graduate Degree). Participants also reported on their history of
treatment for an eating disorder (coded as present or absent).
Analytic plan
All analyses were conducted with SPSS v. 18.0 (SPSS Inc., Chicago, Illinois). Data were screened for normality, and skew and
kurtosis were satisfactory on all continuous variables. Outliers were
examined on continuous variables to see if they skewed reported
group means. Overall variable means were compared with ﬁve
percent trimmed means, and group means were also compared
with ﬁve percent trimmed means. Excluding the outer ﬁve percent
of data points did not signiﬁcantly alter the mean or the pattern of
results between groups. Because of this, all outliers were included
in subsequent analyses. Relationships were considered signiﬁcant
when p values were less than 0.05. All tests were two-tailed.
Only high risk women (n ¼ 332) were included in the analyses
that investigated the CIA’s reliability, factor structure, convergent
validity (ﬁrst component of construct validity), and criterion validity. The entire sample (n ¼ 543) was used to examine the CIA’s
discriminant validity (second component of construct validity).
Cronbach’s alpha and item-total correlations were used to test the
internal consistency of the CIA. Following procedures from prior
CIA studies (Bohn et al., 2008; Reas et al., 2010), a principal
components factor analysis examining solutions with varimax and
oblimin rotations was used to investigate the CIA’s dimensionality.
To assess the CIA’s convergent validity, Pearson correlation coefﬁcients examined the relation between EDE-Q global score and
subscales (restraint, eating concern, weight concern, shape
concern) and CIA global scores. The CIA’s discriminant validity was
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examined using a one-way analysis of variance (ANOVA). Eating
disorder risk status (coded as low risk control, high risk, and clinical
eating disorder) was the independent variable and CIA global score
was the dependent variable. If the omnibus test was signiﬁcant,
a Tukey’s HSD post hoc test examined group differences. Independent samples t-tests were used to investigate the CIA’s criterion
validity. Similar to procedures used in a prior study of the CIA
(Becker et al., 2010), the independent variables were the presence
of eating disorder symptoms in the past three months (objective
binge episodes, subjective binge episodes, purging behaviors,
driven exercise) and the presence of an eating disorder treatment
history, and the dependent variable was the CIA global score.
Descriptive statistics were used to present normative data for
the low risk control, high risk, and clinical eating disorder groups.
Independent samples t-tests were used to compare differences in
mean CIA global scores across studies. The low risk control group
and high risk group were each compared to norms from two
community samples characterized by low pathology (Reas et al.,
2010; Welch et al., 2011). The clinical eating disorder group was
compared with norms from two clinical samples (Bohn et al., 2008;
Welch et al., 2011).
In contrast to general health-related quality of life measures that
provide a global assessment of distress and functional impairment
related to overall mental health, the CIA was designed to capture
clinical impairment that is speciﬁcally due to eating disorder
symptoms (Bohn et al., 2008). To ensure the validity of the
instrument, it is important to conﬁrm that the CIA captures the
severity of clinical impairment related to an individual’s eating
disorder features above and beyond other forms of general
psychopathology, distress, or problems s/he may be experiencing.
Therefore, we attempted to disentangle the CIA’s subjective
appraisal of clinical impairment related to eating pathology from
subjective reports of general psychological distress. In line with
procedures from a prior study of the CIA (Becker et al., 2010), we
explored the utility of including the BDI and STAI as covariates
when conducting all analyses to control for subjective reports of
general psychological distress. All results remained signiﬁcant and
the pattern of ﬁndings was unchanged when controlling for BDI
and STAI scores. Therefore, an in-depth description of these results
is not presented; however, a detailed summary of these ﬁndings is
available upon request.
Results
Participants were college-age women (20.6  2.0 years) who
were at high risk for eating disorder onset (n ¼ 332, 61.1%), diagnosed with a clinical eating disorder (n ¼ 118, 21.7%), or at low risk
(n ¼ 93, 17.1%). The racial/ethnic breakdown of the overall sample
was 55.6% non-Hispanic White (n ¼ 305), 21.6% Asian/Asian American (n ¼ 119), 8.7% African/African American (n ¼ 48), 8.4% Hispanic/
Latino/Mexican American (n ¼ 46), 3.3% Multi-ethnic (n ¼ 18), and
2.4% Other (n ¼ 13). Parents’ highest level of education was a graduate degree for 46.1% (n ¼ 253), a college degree for 24.7% (n ¼ 136),
a high school degree for 27.0% (n ¼ 148), and less than high school for
2.2% (n ¼ 12). Approximately 3.6% (n ¼ 20) of women reported that
they previously received treatment for an eating disorder. Table 1
presents demographic data separated by risk group.
Internal consistency and factor structure
Among high risk women, the CIA demonstrated high internal
consistency (Cronbach’s a ¼ 0.93), and item-total correlations were
signiﬁcantly and positively associated with the total score (rs
range ¼ 0.57 to 0.81, ps < 0.001).

Table 1
Participant characteristics for women at low risk for eating disorder onset, at high
risk for eating disorder onset, and with a clinical eating disorder.

Age (years)
Racial/ethnic breakdown (%)
Non-Hispanic White
African American
Asian Americana
Hispanic/Latino/Mexican
Multi-ethnic
Other
Highest level of parental
education (%)b
Less than high school
High school graduate
College graduate
Graduate degree
Previous treatment for
an eating disorder (%)*
a
b

Low risk
(n ¼ 118)

High risk
(n ¼ 332)

Clinical eating
disorder (n ¼ 93)

20.4  1.9

20.6  1.9

20.7  2.1

55.8
6.5
30.1
3.2
2.2
2.2

56.4
9.9
18.4
8.7
3.3
3.3

53.5
7.6
22.9
11.0
4.2
0.8

0.0
26.9
24.7
48.4
0.0

2.1
27.1
26.2
44.3
3.0

3.4
25.4
21.2
50.0
8.5

p < 0.05.
n ¼ 1 from high risk group did not know highest level of parental education.

Among high risk women, the 16 items of the CIA fell into three
components with eigenvalues exceeding 1, which explained a total
of 68.3% of the variance. Eigenvalues and factor loadings for the
varimax rotation are presented in Table 2. Varimax and oblimin
rotations yielded similar results. The original factor structure was
retained, indicating the presence of three subscales (personal
impairment, cognitive impairment, and social impairment). Cronbach’s alphas for the three subscales were 0.92, 0.85, and 0.86 for
the personal, cognitive, and social impairment subscales, respectively, indicating high internal consistency.
Construct validity
Convergent validity
Among high risk women, CIA global scores were signiﬁcantly and
positively correlated with EDE-Q global scores (r ¼ 0.70; p < 0.001)
and the four EDE-Q subscales (all ps < 0.001; restraint: r ¼ 0.27;
eating concern: r ¼ 0.68; shape concern: r ¼ 0.66; weight concern:
r ¼ 0.65). When controlling for BDI and STAI scores, the relationship
between eating disorder psychopathology and CIA global scores
remained signiﬁcant for all analyses. Moreover, the magnitude of
change in the correlation coefﬁcients was small when controlling for
these covariates, ranging from decreases between 0.01 and 0.09.
Discriminant validity
CIA scores differed by eating disorder risk status, F(2,
538) ¼ 74.5; p < 0.001. Tukey HSD post hoc tests revealed signiﬁcant differences among all three eating disorder risk groups.
Consistent with the level of eating disorder risk, mean CIA global
scores were highest among women with a clinical eating disorder
(17.8  10.6) followed by women at high risk for eating disorder
onset (10.6  8.5) and women at low risk (3.0  3.3), respectively
(Fig. 1). The results remained signiﬁcant after accounting for
general psychological distress (BDI and STAI scores) and the means
were not signiﬁcantly altered.
Criterion validity
Fig. 2 depicts the results of analyses examining criterion validity
in the high risk sample. CIA global scores were signiﬁcantly higher
among those who reported the presence of objective binge
episodes in the past three months (14.6  10.0) compared to those
who did not (9.6  7.8), t(89) ¼ 3.8, p < 0.001. Similarly, CIA global
scores were signiﬁcantly greater in high risk women reporting the
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Table 2
Pattern matrix for principal components analysis with varimax rotation of the three factor structure solution of Clinical Impairment Assessment (CIA) items.
Component 1 (personal
impairment)

Component 2 (cognitive
impairment)

Eigenvalues
7.87
1.91
% of variance explained
49.16
11.93
Item
Over the past month, to what extent have your eating habits, exercising, or feelings about your eating, shape, or weight.
.made you feel ashamed of yourself?
0.85
.made you upset?
0.83
.made you feel guilty?
0.83
.made you feel critical of yourself?
0.81
.made you worry?
0.74
.made you feel like a failure?
0.71
.made you forgetful?
0.84
.made you absent-minded?
0.81
.affected your work performance (if applicable)?
0.71
.affected your ability to make everyday decisions?
0.65
.made it difﬁcult to concentrate?
0.58
.interfered with you doing things you used to enjoy?
.interfered with meals with family or friends?
.stopped your from going out with others?
.made it difﬁcult to eat out with others?
.interfered with your relationships with others?
Mean  SD
6.8  4.8
2.6  2.8
Median (range)
6 (0e18)
2 (0e17)

presence of subjective binge episodes in the previous three months
(14.5  9.0) than high risk women without subjective binge
episodes (8.4  7.4), t(219) ¼ 6.4, p < 0.001. CIA global scores were
also signiﬁcantly higher among those reporting the presence of
purging behaviors in the past three months (16.3  11.1) compared
to those who did not (10.2  8.1), t(27) ¼ 2.8, p ¼ 0.01. As
compared to those without driven exercise (10.4  8.5), high risk
women reporting driven exercise in the previous three months had
signiﬁcantly higher CIA global scores (14.6  8.4), t(329) ¼ 2.0,
p ¼ 0.05. Finally, high risk women with a history of eating disorder
treatment reported signiﬁcantly greater CIA scores (18.9  12.2)
than those without a prior treatment history (10.4  8.3),
t(9) ¼ 2.1, p ¼ 0.05. The results remained signiﬁcant after
accounting for general psychological distress (BDI and STAI scores)
and the means were not signiﬁcantly altered.
Normative data

0.50
0.79
0.79
0.77
0.59
2.3  3.0
1 (0e15)

Discussion
The Clinical Impairment Assessment (CIA) was developed to
capture impairment in psychosocial domains among individuals
with varying levels of eating disorder symptom severity (Bohn &
Fairburn, 2008). The current study was the ﬁrst to examine the
psychometric properties of the CIA among a sample of women at
high risk for developing an eating disorder. Results indicate that the

25

Yes
No

20
15

*p < 0.05

10
5
0

Fig. 1. Discriminant validity of the Clinical Impairment Assessment (CIA): Comparison
of CIA global scores among low risk controls (n ¼ 118), high risk women (n ¼ 332), and
women with a clinical eating disorder (ED; n ¼ 93). Note: Different letters represent
signiﬁcant differences between groups at the p < 0.05 level.

1.15
7.19

mean CIA global scores (3.0  3.3) than community samples from
Norway (6.4  7.5), t(554) ¼ 4.4, p < 0.001, and from Sweden
(8.3  9.4), t(219) ¼ 5.7, p < 0.001. The high risk group reported
signiﬁcantly higher mean CIA global scores than the Norwegian
sample, t(768) ¼ 7.4, p < 0.001, and the Swedish sample,
t(1090) ¼ 4.1, p < 0.001. The clinical eating disorder group in the
current study had signiﬁcantly lower mean CIA global scores
(17.8  10.6) as compared to clinical samples from the United
Kingdom (31.2  9.9), t(214) ¼ 9.6, p < 0.001, and Sweden
(30.2  10.2), t(2474) ¼ 11.5, p < 0.001.

CIA Global Score

Table 3 presents the means and standard deviations, as well as
corresponding percentile rank values, for the CIA global score in the
low risk control, high risk, and clinical eating disorder groups. The
low risk control group in the current study had signiﬁcantly lower

Component 3 (social
impairment)

OBE

SBE

Purging Exercise

ED Tx

Fig. 2. Criterion validity of the Clinical Impairment Assessment (CIA) in women at high
risk for eating disorder onset: comparison of CIA global scores among high risk women
with and without eating disorder (ED) symptoms. Note: The presence of the following
symptoms in the three months prior to assessment were assessing with the Eating
Disorder Examination: OBE ¼ Objective binge episodes, SBE ¼ Subjective binge
episodes, Purging ¼ Purging behaviors (vomiting, laxative use, diuretic use), and
Exercise ¼ Driven exercise. Participants also reported on their lifetime history of any
treatment for an eating disorder (ED Tx).
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Table 3
Normative data for Clinical Impairment Assessment (CIA) global scores in collegeage women at low risk for an eating disorder, at high risk for eating disorder
onset, and with a clinical eating disorder.

Mean  SD
Percentile rank
5
10
25
50
75
90
95
100

Low risk
(n ¼ 118)

High risk
(n ¼ 332)

Clinical eating
disorder (n ¼ 93)

3.3  3.6

10.7  8.5

17.8  10.6

0.0
0.0
0.0
2.0
5.0
9.0
11.0
16.0

0.0
1.0
4.0
9.0
16.0
23.0
28.0
43.0

3.0
4.0
10.0
16.0
25.0
32.0
38.0
48.0

CIA demonstrated strong psychometric properties within our
sample of high risk women and revealed meaningful patterns of
clinical impairment among clinical eating disorder, high risk, and
low risk control women. Thus, our data indicate that the CIA is
a reliable and valid tool for assessing the pervasive impact of eating
disorder symptoms on functioning across important domains in
college-age women.
Findings suggest that the CIA is a reliable measure among high
risk women, as it demonstrated high internal consistency (Cronbach’s a ¼ 0.93) and item-total correlation values were moderate to
strong (rs range ¼ 0.56e0.81). Among this high risk sample, the CIA
measured a cohesive construct and all individual items appeared to
contribute to the CIA global scoredthe designated index of
impairment severity (Bohn et al., 2008). These results are comparable to the reliability testing in prior studies of the CIA with
community and clinical samples (Bohn et al., 2008; Reas et al.,
2010). The three factor structure of the CIA, which includes
personal, cognitive, and social impairment subscales, that was
previously described (Bohn et al., 2008; Reas et al., 2010) was
replicated in the current study. Each of the subscales demonstrated
high internal consistency (Cronbach’s a ¼ 0.85e0.92). These ﬁndings support the use of both global and domain-speciﬁc CIA scores
to assess impairment related to eating disorder features. Overall,
ﬁndings from the current study and prior work support the reliability and factor structure of the CIA in samples characterized by
low eating pathology, disordered eating pathology that places
individuals at high risk for eating disorder onset, and full syndrome
eating disorders.
The CIA demonstrated good construct validity in the current
study. Self-reported eating pathology, as assessed by the global and
subscale scores of the Eating Disorder Examination Questionnaire
(EDE-Q), was positively correlated with global CIA scores among
high risk women. These ﬁndings are consistent with prior studies of
the CIA in eating disorder samples (Becker et al., 2010; Bohn et al.,
2008) and in women with low pathology from the general population (Reas et al., 2010). The CIA also discriminated between
women across the spectrum of eating disorder risk. Women with
clinical eating disorders reported the highest CIA global scores,
while women in the low risk control group reported the lowest CIA
global scores. As expected, women at high risk for eating disorder
onset reported signiﬁcantly less clinical impairment than women
with a clinical eating disorder but signiﬁcantly more impairment
than women with very low pathology. In general, the CIA appears to
differentiate among women across the spectrum of disordered
eating, lending strength to the clinical utility of the instrument.
Findings also highlight that it may be possible to more clearly
operationalize the construct of clinical impairment for mental
disorders, which is currently somewhat ambiguous, using a brief
self-report measure similar to the structure of the CIA.

Findings indicated that the CIA has good criterion validity with
indices of eating disorder psychopathology among women at high
risk for eating disorder onset. The presence of objective binge
episodes was associated with signiﬁcantly higher CIA global scores
than the absence of objective binge episodes, corresponding to the
only prior examination of criterion validity of the CIA that took
place in Fijian adolescent schoolgirls (Becker et al., 2010). Notably,
the severity of clinical impairment, as assessed by CIA global scores,
was comparable between the presence of objective and subjective
binge episodes. These data imply that the presence of a binge
episode regardless of size may be clinically meaningfuldat least
among this high risk sampledwhich supports emerging research
indicating that the experience of loss of control may be more salient
than the size of a binge episode (Wolfe, Wood Baker, Smith, & KellyWeeder, 2009). Further, high risk women reporting purging
behaviors had signiﬁcantly greater CIA global scores than those
without any purging behaviors. This differs from Becker et al.’s
(2010) study in which adolescent females who endorsed vomiting
or laxative use did not signiﬁcantly differ on CIA global scores from
those without these purging behaviors. It is possible that purging
behaviors are simply not indicative of impairment in Fijian cultures
because they may be more socially acceptable, whereas purging
behaviors are good markers of impairment in the United States
because they are culturally associated with more social distress and
shame. Key differences between samples, including age or the
overall severity of eating pathology, may also account for these
inconsistent ﬁndings. Finally, high risk women reporting driven
exerciseda key non-purging behaviordhad higher CIA global
scores. Overall, the CIA appears to capture clinical impairment
related to a broad range of indices of eating disorder psychopathology among this high risk sample. These ﬁndings also highlight
the importance of examining clinical impairment in relation to
indices of psychopathology across cultures, as this may have
important implications for the universality of current diagnostic
criteria that requires individuals to experience distress or functional impairment related to their mental disorder symptoms.
In our examination of the CIA’s criterion validity, results indicate
that high risk women reporting a history of eating disorder treatment had clinically signiﬁcant impairment related to their symptoms. High risk women with an eating disorder treatment history
reported a mean CIA global score of approximately 19, which is
comparable to prior data suggesting that a CIA global score of 16 is
indicative of a full syndrome eating disorder case (Bohn et al., 2008)
and our current mean CIA global score of 18 among women with
eating disorders. Since high risk status in the current study was
deﬁned by the presence of elevated weight and shape concerns, it is
possible that disordered eating attitudes continued to linger despite
previous treatment or that this eating pathology resurfaced
following treatment cessation. This residual eating pathology or
clinical impairment may place these women with a previous
treatment history at an especially high risk for relapse. Consistent
with this notion, research suggests that the presence of elevated
weight and shape concerns following the cessation of treatment for
an eating disorder is a risk factor for relapse into a full syndrome
eating disorder (Carter, Blackmore, Sutandar-Pinnock, & Woodside,
2004; Channon & deSilva, 1985; Keel, Dorer, Franko, Jackson, &
Herzog, 2005; McFarlane, Olmsted, & Trottier, 2008). Prospective
data also indicate that psychosocial dysfunction following symptom
remission was a predictor of relapse among individuals with
bulimia nervosa (Keel et al., 2005). The characterization of the role
of clinical impairment in the risk for relapse from an eating disorder
is sorely needed; it may be also be worthwhile to investigate
whether the notion of “recovery” from an eating disorder may need
to include a greater emphasis on level of clinical impairment. The
CIA appears to be a useful tool to assess impairment in such studies.
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Additionally, ﬁndings point to the potential importance of incorporating relapse prevention strategies into routine clinical practice.
In addition to examining the psychometric properties of the CIA
among a high risk sample, we also sought to provide the ﬁrst
normative data for the CIA in non-treatment seeking, college-age
women with varying levels of eating disorder psychopathology
from the United States. Women with a clinical eating disorder had
an average CIA global score of approximately 18. This clinical norm
was signiﬁcantly lower than the clinical samples of young Swedish
women and individuals from the United Kingdom (CIA global
scores of w30) (Bohn et al., 2008; Welch et al., 2011), but appears
similar to the recommended clinical cut-off score of 16 (Bohn et al.,
2008). Women at high risk for developing an eating disorder
reported a mean CIA global score of approximately 11, which was
signiﬁcantly higher than norms from community samples of young
women characterized by low pathology (Reas et al., 2010; Welch
et al., 2011). This study provides the ﬁrst account of the severity
of impairment among a high risk, college-age population, which
may be greater than the general population. Finally, women with
very low pathology in the current study had an average CIA global
score of 3, which was signiﬁcantly lower than prior studies ﬁnding
mean CIA global scores between 6 and 8 in the general population
(Reas et al., 2010; Welch et al., 2011). However, it is likely that these
general population samples also included women at high risk for
eating disorder onset or with signiﬁcant subclinical pathology,
accounting for these higher norms.
Some caution should be exerted when interpreting differences in
scores and when generalizing the norms from the current study to
the general United States population. Our norms represent
a college-age population of women who self-selected for the study
based on body image concerns, interpersonal problems, or
concentration difﬁculties in school. However, these issues are
common among college-age women and so a broad base of the
population was likely reached. It is also noteworthy that women
were recruited from a diverse array of schoolsdranging from
community colleges to private universitiesdand represented
a wide range of socioeconomic status and racial/ethnic backgrounds
from two areas of the United States. Moreover, scores on the Weight
Concerns Scale (Killen et al., 1994)dthe study’s assessment of body
image concernsdwere normally distributed across the nearly entire
range of potential scores (0 to 95 out of a possible 0 to 100 range)
and the sample mean and median (M ¼ 54.1; median ¼ 56) was very
close to the center of the distribution of the range. Therefore, our
norms are likely representative of the college-age women, but
large-scale, epidemiological studies in the United States are needed
to make this determination. More work is needed in culturally- and
demographically-diverse settings to replicate these ﬁndings.
A primary strength of the current study is the large sample of
young women at high risk for an eating disorder by virtue of having
elevated weight and shape concerns, which captures a critical
subthreshold group. The study’s attempts to disentangle women’s
subjective appraisals of clinical impairment related to eating
pathology from subjective reports of general psychological distress
also represents a signiﬁcant strength. Overall, these results suggest
that the CIA is sensitive to differences in self-evaluations of clinical
impairment due to eating disorder symptoms independent of
subjective reports of general psychological distress. These analyses
allow us to feel more conﬁdent that the CIA is assessing impairment
that is the direct result of eating disorder featuresda critical
criterion for deﬁning a mental disorder in DSM-5 (Stein et al., 2010).
The current study is also the ﬁrst study of the CIA in a sample from
the United States and provides needed normative data. The inclusion of clinical eating disorder and low risk groups is another key
strength because it allowed the study to capture clinical impairment across a individuals with varied levels of pathology and to
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examine the discriminant validity of the CIA with an adequate
sample size. Our sample was also more ethnically diverse compared
to most prior CIA studies in women (Bohn et al., 2008; Reas et al.,
2010; Welch et al., 2011), which occurred primarily in Caucasians.
Limitations of the current study include the limited age range of
the sample (most individuals were between 18 and 22 years) and
that it was comprised entirely of women. However, earlier work
primarily examined the CIA among young women as well, which
allowed us to more easily interpret results across studies during
these early psychometric studies of the CIA. Further investigation of
the CIA among racially/ethnically diverse populations, men, and
individuals spanning a broad age range is required to increase the
generalizability of ﬁndings related to the CIA’s clinical utility.
Additionally, the current study did not use objective measures of
clinical impairment, such as expert clinician ratings or collateral
reports, to provide a more stringent test of construct validity. More
research is needed to examine the association between the CIA and
blinded, external ratings of clinical impairment among individuals
who endorse a range of disordered eating attitudes and behaviors.
Finally, the cross-sectional nature of the study design limits our
ability to make causal inferences about the relation between the
development of eating disorder symptoms and clinical impairment.
The CIA, however, does attempt to capture causality by asking
participants to rate the extent to which they are impaired because of
the experience of eating pathology. It is critical for future studies to
examine the performance of the CIA prospectively and throughout
the course of treatment to investigate its predictive validity and
utility as an outcome measure.
Overall, the current study indicates that the CIA is a psychometrically strong measure among young women at high risk for
eating disorder onset and is useful for differentiating subgroups of
individuals with varying levels of eating disorder psychopathology.
Our results provide the ﬁrst set of norms for the CIA in a United
States sample of college-age women. Clinical impairment, as
measured by the CIA, should be considered an important construct
of clinical research, diagnostic decision-making, and treatment
assessment over time. Given the promising ﬁndings associated
with the CIA and the increasing importance of clinical impairment
recommended for inclusion in the forthcoming DSM-5 (APA, 2010;
Stein et al., 2010), future studies should consider evaluating clinical
impairment instruments similar to the CIA across a broader range
of mental disorders.
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